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Background. Recent literature suggests that chyle leak may complicate up to 10% of pancreatic
resections. Treatment depends on its severity, which may include chylous ascites. No international
consensus definition or grading system of chyle leak currently is available.
Methods. The International Study Group on Pancreatic Surgery, an international panel of pancreatic
surgeons working in well-known, high-volume centers, reviewed the literature and worked together to
establish a consensus on the definition and classification of chyle leak after pancreatic operation.
Results. Chyle leak was defined as output of milky-colored fluid from a drain, drain site, or wound on or
after postoperative day 3, with a triglyceride content $110 mg/dL ($1.2 mmol/L). Three different
grades of severity were defined according to the management needed: grade A, no specific intervention
other than oral dietary restrictions; grade B, prolongation of hospital stay, nasoenteral nutrition with
dietary restriction, total parenteral nutrition, octreotide, maintenance of surgical drains, or placement of
new percutaneous drains; and grade C, need for other more invasive in-hospital treatment, intensive
care unit admission, or mortality.
Conclusion. This classification and grading system for chyle leak after pancreatic resection allows for
comparison of outcomes between series. As with the other the International Study Group on Pancreatic
Surgery consensus statements, this classification should facilitate communication and evaluation of
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Medicine, Baltimore, MDCHYLE LEAK (CL) is a well-recognized and
potentially serious complication after abdominal
operation. Recent literature suggests that intra-
abdominal CL, which includes chylous ascites as
well, may occur in up to 10% of patients after
pancreatic resections.1 Due to increasing numbers
of extended resections being performed, the inci-
dence of CL might increase further.
Chyle is the lymphatic fluid in the wall of the
bowel consisting of an emulsion of lymph and
triglyceride fat (chylomicrons); chyle is trans-
ported from the lymphatic vessels in the wall of
the intestine to the lymphatic vessels in the
mesentery, where they coalesce into the cisterna
chyli, which joins the thoracic duct to drain into
the venous circulation.2 The cisterna chyli and its
major branches, located anterior to the first and
second lumbar vertebrae at the same level of the
pancreatic head and neck, may be injured during
pancreatic resections, especially pancreatoduode-
nectomy.3,4 CL may induce malnutrition and lead
to an immune compromised state.5
The International Study Group of Pancreatic
Surgery (ISGPS) has introduced several interna-
tional consensus definitions and grading systems
for the most common complications of pancreatic
operation, including pancreatic fistula, delayed
gastric emptying, and postpancreatectomy hemor-
rhage, and consensus definitions for borderline
resectable pancreatic cancer, pancreatic anastomo-
ses, extended resections, and standard lymphade-
nectomy.6-12 These grading systems have been well
accepted and adopted in the literature and have
been used extensively to allow accurate compari-
son of outcomes across institutions and countries.
Intra-abdominal CL seems to occur primarily
after pancreatic resection, but the reported inci-
dence varies widely, probably due to a lack of
uniformity in definitions of CL.13-15 Using strict
criteria, a recent large series demonstrated thepresence of a CL in 12.5% of patients after pan-
creatoduodenectomy and found that initial and
maximum drainage volumes were associated with
the duration of hospital stay and time to resolution
of CL.1 A uniform and, more importantly, an
objective definition of CL does not exist. Further-
more, there is no consensus on an optimal treat-
ment strategy for CL and chylous ascites.
Restriction of long-chain triglycerides by a low-fat
diet or total parenteral nutrition (TPN) will
decrease lymph flow, thus decreasing the volume
of the CL with eventual resolution. Medium-
chain-triglycerides (MCT) often are introduced
in the low-fat diet, because these MCTs are not ab-
sorbed via the gut lymphatics and help to increase
the calorie intake of the patient. MCT can be trans-
ported across the enterocyte and into the mesen-
teric venous circulation; this process does not
require transport into the mesenteric lymphatics.16
The aim of the ISGPS was to develop a univer-
sal, objective definition, classification, and grading
system for CL after pancreatic operation. Such a
definition should allow valid assessment and com-
parison of studies across institutions and countries
regarding this complication.
METHODS
An in-depth review of the literature on CL after
pancreatic operation was performed by the ISGPS, an
internationalpanelofpancreatic surgeonsallworking
in well-known, high-volume centers and each with
considerable clinical and scientific experience.
A systematic search of the PubMed and the
Cochrane electronic databases was performed in
July 2015, including the terms “chylous ascites” and
“chyle” in the medical subject headings. An addi-
tional free search term limited results to articles
related to the pancreas. Terms were combined with
Boolean operators. A non-MeSH search also was
performed. Studies of any design investigating
344Records identified through 
database searching
(n = 505)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
Id
en
tif
ic
at
io
n Additional records identified 
through other sources
(n = 1)
Records after duplicates removed
(n = 363)
Records screened
(n = 363)
Records excluded
(n = 335)
Full-text articles 
assessed for eligibility
(n = 28)
Full-text articles 
excluded, with reasons
(n = 14)
Not specifically 
investigating CL, n= 4
Other organ, n= 4
Review, n= 3
Article not available, n= 1
Other, n= 2
Studies included in 
qualitative synthesis
(n = 14)
Fig. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram.
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included. The language of the selected articles was
limited to English. Case reports were included to
capture potentially rare but effectivenovel treatment
strategies for uncontrolled CL. The title and abstract
and subsequently the full-text articles of all poten-
tially relevant studies were screened for relevance by
2 independent reviewers (L.B.R. and R.S.). Refer-
ence lists and related articles in PubMed of all
includedarticles were reviewed to ensure no relevant
studies were missed. Discrepancies were discussed,
and any doubts were resolved through discussion
with a third author (M.G.B. orD.J.G.). ThePreferred
Reporting Items for Systematic Reviews and Meta-
Analyses guidelines were followed.17
The first concept of the review and a suggested
definition was circulated to all ISGPS participants.
All authors were required to provide substantialfeedback on the manuscript or consensus defini-
tion. Comments or suggestions were gathered and
discussed within a dedicated subgroup, after which
a new version was composed and again circulated
to all participants; relevant comments from the
members of the ISGPS were gathered again and
included in subsequent drafts until, after 6 ver-
sions during a period of 9 months, a final
consensus statement was reached and confirmed
by all authors. All feedback of participants to the
coordinators was discussed routinely by other
ISGPS members via e-mail.
Assessment of methodological quality. The
methodologic quality of included studies was as-
sessed. All studies were graded according to the
evidence-based library and information practice
critical appraisal checklist developed by Glynn.18
An overall validity calculation of $75% indicates
Table I. Study characteristics of chyle leaks after pancreatic operation
Study Year Country Design No. patients Validity (%)
Pan et al19 2015 China Retrospective cohort study 1,921 95
Corradini et al20 2015 Germany Case report 1 Case report
Abu Hilal et al15 2013 UK Retrospective cohort study 245 95
Kim et al21 2013 South Korea Retrospective cohort study 222 90
Kuboki et al22 2013 Japan Retrospective cohort study 574 90
Noji et al23 2012 Japan Retrospective cohort study 138 90
D’Hondt et al24 2011 Belgium Case report 1 Case report
Aoki et al25 2010 Japan Retrospective and prospective
cohort study
86 86
Van Der Gaag et al26 2008 The Netherlands Retrospective cohort study 609 95
Assumpcao et al14 2008 USA Match-controlled cohort study 3,532 86
Malik et al27 2007 UK Retrospective cohort study 105 85
Madanur et al28 2007 UK Retrospective cohort study 138 84
Kollmar et al29 2000 Switzerland Case report 1 Case report
Cope30 1998 USA Prospective cohort (feasibility) study 1 Case report
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assess the methodological quality of case reports.
RESULTS
Literature review. The search revealed 505
studies, 14 of which were eligible for data extraction.
The Figure depicts the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses flow dia-
gram for study selection. Table I depicts general
study characteristics.14,15,19-30 From a total of 7,574
patients undergoing pancreatic resection, 224 pa-
tients (3.0%) were reported to have developed a
CL; the incidences across individual studies ranged
from 1–16%.
Definitions. Nine studies reported a definition
for CL after pancreatic resection (Table II).
Although similar, none of the studies adhered to
the same definition. Most studies incorporated
the appearance of drainage fluid (milky/white)
and assessment of the triglyceride concentration
in the fluid ranging from $110 to >130 mg/dL
(1.2–1.4 mmol/L). The volume of drainage (if
an intra-abdominal drain was present) also was
noted often, with different cut-off values ranging
between $100 mL and >600 mL per day.
Independent risk factors. Three studies identi-
fied early enteral feeding as an independent risk
factor for the onset of CL.21-23 Dissection of the para-
aortic area was identified as a risk factor for develop-
ment of CL in 2 studies, as were the extent of lymph
node dissection, the presence of retroperitoneal in-
vasion, chronic pancreatitis, and total number of
lymph nodes harvested.14,15,19,22,26 Other identified
independent risk factors included dissection in the
area of the root of the superior mesenteric artery,
lymphovascular invasion, neoadjuvant therapy,vascular resection, female sex, and postoperative
portal or mesenteric venous thrombosis.15,19,26
Management. CL usually was recognized at a
median of 5–6 days postoperatively. Of the 224
patients who developed CL, 24 (11%) patients did
not receive any specific treatment and recovered
uneventfully.21,26 Primary treatment consisted most
often of oral/enteral dietary measures (53%,
n = 119) or TPN (51%, n = 114).14,21-23,25-27
The pooled success rate of CL treatment across
all included studies was 95% (213/224 patients).
Five studies did not report a 100% success rate. In
1 study, 7 of 47 patients treated with TPN or
octreotide required additional lymphoscintigra-
phy, lymphangiography, sclerotic (ie, lymphatic)
embolization, or reoperation.14 In another study, 1
of the 7 patients treated with TPN eventually was
treated successfully with a peritoneovenous
shunt.27 In a case report of 1 patient, radiation
treatment seemed to be successful when TPN
failed.20 One out of 3 patients treated with abdom-
inal paracentesis and MCT-diet alone required
additional TPN in 1 study, and in a final older
case report percutaneous transabdominal catheter-
ization of the cisterna chyli failed and the patient
subsequently underwent successful peritoneove-
nous shunt insertion.28,30
Dietary measures included a low-fat diet with
restriction of long-chain triglycerides (46%), an
MCT diet (40%), and a fat-free diet (3%).14,15,21,26,28
In 1 study, octreotide was combined with TPN in 5
patients.25 Three studies noted that somatostatin had
been used perioperatively in an attempt to decrease
the incidence of pancreatic leak after the pancreatec-
tomy.15,26,27 Three studies used routine, early postop-
erative enteral feeding during the study period.23,26,27
Table II. Definitions and incidence of chyle leak after pancreatic operation
Study Drain volume Appearance of fluid
Triglyceride
concentration in fluid
Other findings in the
fluid Incidence
Pan et al19 $100 mL/d Milky or creamy $110 mg/dL Noninfectious 3%
Corradini et al20 — — — Case report
Abu Hilal et al15 >200 mL/d Milky >130 mg/dL Amylase normal 16%
Kim et al21 Any Milky >110 mg/dL 11%
Kuboki et al22 $100 mL/d Milky $110 mg/dL Amylase-free 3%
Noji et al23 — Milky >110 mg/dL Onset of drainage
with start of
enteral feeding
Decrease in volume
of drainage with
discontinuing
enteral feeds
8%
D’Hondt et al24 — — — Case report
Aoki et al25 — Milky, non-purulent >110 mg/dL 7%
Van Der Gaag et al26 $275 mL/d Milky >110 mg/dL Onset of drainage
with start of
enteral feeding
11%
Assumpcao et al14 $200 mL/d Milky $110 mg/dL Low amylase 1%
Malik et al27 >600 mL/d — — Amylase-free
Contains
chylomicrons
Bile-free
7%
Madanur et al28 — — — 2%
Kollmar et al29 — — — Case report
Cope30 — — — Case report
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crease in hospital stay associated with the CL, but
not all studies addressed hospital stay.15,23,25,26 In 1
study, CL was associated with a significantly greater
duration of abdominal drainage (14 vs 10 days)
and an increased incidence of portal or mesenteric
venous thrombosis (8% vs 2%).15 Other associated
complications of CL were reported; in 1 study of 86
patients, complications included malnutrition
defined as serum albumin <3.5 mg/dL (92%),
sepsis (13%), peritonitis (6%), abscess (4%), and
concomitant pancreatic fistula (4%).14 In another
study 1 of 3 patients was unable to receive adjuvant
chemotherapy due to poor health caused by the
CL.28 The ability or lack thereof in receiving adju-
vant chemo- and or radiotherapy was not ad-
dressed in the other studies.
Consensus definition. Based on the findings,
the ISGPS proposes the following definition of
CL after pancreatic operation with the grading
system outlined in Table III. CL is defined as the
output of milky-colored fluid from a drain, drain
site, or wound, on or after postoperative day 3,
with a triglyceride content $110 mg/dL or
$1.2 mmol/L. Three different grades (A, B,
and C) were defined according to the clinicalscenario, management, and duration of hospital
stay. The proposed definition and grading system
applies to isolated CL. In the event of other,
simultaneous complications, such as high amylase
levels in case of postoperative pancreatic fistula as
described by the ISGPF, both grading systems
should be used in combination.6
Grade A implies a clinically irrelevant CL. There
should be no prolongation of hospital stay and a
conservative approach with only restrictions in the
oral diet.
Grade B requires that 1 of the following criteria
is fulfilled: nasoenteral nutrition with dietary re-
striction and/or TPN, percutaneous catheter
drainage by interventional radiology or mainte-
nance of the surgical drains, or drug treatments
(eg, octreotide) to control the CL. Grade B results
in a prolonged hospital stay related directly to the
CL. A patient might be discharged with the surgi-
cal drain in situ or be readmitted for CL.
Grade C requires more invasive treatment such
as by interventional radiology involving lymphatic
embolization/sclerosis, admission to an intensive
care unit, operative exploration and peritoneove-
nous shunt, or implies mortality directly due to the
CL. Patients readmitted for management of CL for
Table III. ISGPS consensus definition and grading system for isolated chyle leak after pancreatic resection
CL is defined as the output of milky-colored fluid from a drain, drain site, or wound, on or after postoperative day 3, with a triglyceride
content $110 mg/dL or $1.2 mmol/L.
Grade A Grade B Grade C
Therapeutic consequence None or oral dietary
restrictions*
Nasoenteral nutrition with
dietary restriction* and/
or TPN, percutaneous
drainage by IR,
maintenance of surgical
drains, or drug (eg,
octreotide) treatment
Other invasive in-hospital
treatment,y admission to
the intensive care unit,
and/or mortalityz
Discharge with (surgical)
drain or readmissionz
No Possibly Possibly
Prolonged hospital stayz No Yes Yes
*No-fat diet with/without medium-chain-triglyceride.
yInterventional radiology (excluding percutaneous drainage) or reoperation.
zRelated directly to the chyle leak.
TPN, total parenteral nutrition; IR, Interventional radiology.
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grade B to a grade C CL.
DISCUSSION
The present ISGPS consensus statement pro-
vides a definition for CL after pancreatic opera-
tion, which is intended to be all-inclusive, as
objective as possible, and applicable to all situa-
tions, including chylous ascites. Such a universal
definition should allow for better comparison of
outcomes between centers and should facilitate
new studies concerning this relatively rare but
clinically relevant complication of pancreatic oper-
ation. Fundamental in the development of the
classification system was the clinical relevance of
each criterion and classification to the patient
directly. As in previous ISGPS statements, a full
systematic review was performed including a total
of 7,574 patients undergoing pancreatic resection
in which the incidence of CL was available.
The definition of CL in the literature varied but
most often incorporated the triglyceride concen-
tration, appearance, and daily volume of CL (when
an intra-abdominal drain was present). The ISGPS
agreed that CLs are relevant, regardless of a
minimal reported volume threshold. Furthermore,
previous ISGPS definitions rely on a threshold to
define the presence of the definition which re-
flects a physiologic alteration (eg, an increased
level of the drain amylase activity) rather than
volume.6 A volume threshold was therefore not
incorporated into our definition of CL. In patients
with a low oral/enteral intake, triglyceride concen-
tration may be less than the cut-off of 110 mg/dL
or 1.2 mmol/L, thus leading to a slightunderestimation of the incidence of CL. Because
duration of hospital stay after pancreatic operation
depends strongly on local, cultural, regional as-
pects, we focused on “prolonged hospital stay”
rather than on providing an absolute duration of
hospital stay cut-off.
Some hospital laboratories may determine the
presence of chylomicrons in drainage fluid instead
of triglyceride content. Generally speaking, when
chylomicrons are detected, the drainage fluid
triglyceride content will exceed 110 mg/dL. As
such, the presence of chylomicrons in drainage
fluid may be regarded in these centers equal to a
triglyceride content >110 mg/dL.
In most series, initial noninterventional treat-
ment of CL with dietary restrictions was successful.
No study reported exactly how the response to
treatment was measured (eg, through imaging or
based on clinical parameters such as progressive
decrease in volume of drainage or concentration
of triglyceride). Complication rates were low,
although 4 studies identified a prolonged hospital
stay related directly to the CL.
To our knowledge, no study compared treatment
strategies for CL after pancreatic operation,
although clinically relevant CL complicates up to
10% of pancreatic resections. Additional random-
ized studies comparing different treatment modal-
ities are therefore unlikely. On a pathophysiologic
basis, TPNmay be very effective but is known to carry
more procedure-related complications compared
with dietary restrictions. Therefore, surgeons may
prefer a step-up approach starting with dietary
restrictions (a diet restricted in long-chain triglycer-
ides or a no-fat diet with MCT supplementation); if
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drain output after a few days, TPN may be consid-
ered. Percutaneous catheter drainage of collections
or chylous ascites is advised only in case of clinical
symptoms. If TPN treatment fails, more invasive
treatment options should be considered. Three
strategies have been described: sclerotic (ie,
lymphatic) embolization; a peritoneovenous shunt
to decompress chyle from the peritoneum into the
systemic circulation; and the use of lymphangiog-
raphy to define the site of CL for operative ligation.
However, data on these strategies are very limited,
and success rates seem poor.14,27 Operative ligation
of chyle leaks after an esophagectomy ormediastinal
node dissection after pulmonary resection is both
well described and very effective, but experience
with operative management after pancreatectomy
is very limited.31,32
No evidence-based advice on the timing of
removal of the drains can be given. In contrast,
there also is no reported negative effect of early
drain removal.33,34 Notably, drain removal after
negative cultures combined with closure of past
drain sites has been used as a treatment strategy
by some ISGPS members.
Many studies have reported an association be-
tween the incidence of CL and the start of enteral
feeding or the onset of a full oral diet, which is
probably related to fat absorption from the diet
(ie, long-chain triglyceride) increasing lymphatic
flow and consequently increasing the volume and
normalizing the color of the CL.14,21,25-27 However,
early oral feeding after pancreatectomy is now well
established as routine practice, and there is no ev-
idence that withholding oral intake will decrease
the development of CL itself.25,35-37
Some studies have questioned the necessity of
prophylactic intra-abdominal drainage after
pancreatic resection.38-43 Abandoning intra-
abdominal drainage excludes the possibility of
early detection of CL in the drain output. In this
case, suspicion of CL should be based on the clin-
ical course of the patient and fluid collections seen
on imaging and can be confirmed with percuta-
neous aspiration or drainage.
This consensus statement has limitations, which
are essentially the consequence of the limited
available data. Little information is available
regarding confounding variables, which require
investigation in the future. Also, prospective, large
series regarding interventional treatment of CL are
lacking but probably are not feasible because of
the incidence of CL. In summary, CL is a clinically
relevant complication after pancreatic operation
that almost always responds well to nonoperativemeasures. Considering the generally accepted and
routinely used previous ISGPS definitions, the
current consensus definition and grading system
for CL after pancreatic operation should allow for
valid assessment and comparison of complications
after pancreatic operation.
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